Drug discovery startup Converge Bio Inc. said today it has closed on a $5.5 million seed round of funding to help biotech and pharmaceutical companies develop more effective drugs at faster speeds by ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Generate:Biomedicines today announced key advancements across its clinical pipeline and generative AI platform, including its first patient dosed in GB-0895, ...
A comprehensive new report delves into the groundbreaking advancements in the field of generative biology, an interdisciplinary area at the intersection of computational sciences and biotechnology.
This post was originally published on this site. Proprietary safety intelligence creates dual value: faster therapeutic development and biodefense. LOS ANGELES, CALIFORNIA / ACCESS Newswire / ...
AI-focused biotech Deepcell is partnering with Nvidia to expand its use of generative AI in cell biology, the company announced Monday afternoon. The partnership — unveiled at the JP Morgan Healthcare ...
SOMERVILLE, Mass.--(BUSINESS WIRE)-- Generate:Biomedicines (“Generate”) today announced a multi-target collaboration with Novartis (NYSE: NVS) to discover and develop protein therapeutics across ...
With one program in the clinic and another not far behind, Generate Biomedicines Inc. raised $273 million in a series C financing to advance its generative biology platform. It is one of the largest ...
New Catalog of NVIDIA NIM and GPU-Accelerated Microservices for Biology, Chemistry, Imaging and Healthcare Data Runs in Every NVIDIA DGX Cloud SAN JOSE, Calif.—GTC, March 18, 2024 (GLOBE NEWSWIRE) -- ...
Proprietary safety intelligence creates dual value: faster therapeutic development and biodefense. LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 9, 2025 / Lunai Bioworks Inc. (NASDAQ:RENB), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback